Cargando…
Tofacitinib in patients with refractory Takayasu’s arteritis
Autores principales: | Li, Jing, Li, Mengtao, Tian, Xinping, Zeng, Xiaofeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590403/ https://www.ncbi.nlm.nih.gov/pubmed/32591815 http://dx.doi.org/10.1093/rheumatology/keaa281 |
Ejemplares similares
-
The efficacy of Mycophenolate mofetil for the treatment of Chinese Takayasu’s arteritis
por: Li, Jing, et al.
Publicado: (2016) -
Identification of the Association Between Toll-Like Receptors and T-Cell Activation in Takayasu’s Arteritis
por: Tian, Yixiao, et al.
Publicado: (2022) -
The clinical characteristics of Chinese Takayasu’s arteritis patients: a retrospective study of 411 patients over 24 years
por: Li, Jing, et al.
Publicado: (2017) -
Using the co-expression network of T cell-activation-related genes to assess the disease activity in Takayasu’s arteritis patients
por: Tian, Yixiao, et al.
Publicado: (2021) -
Association between acute phase reactants, interleukin-6, tumor necrosis factor-α, and disease activity in Takayasu’s arteritis patients
por: Li, Jing, et al.
Publicado: (2020)